These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 25600358)
41. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens. Andersen JM; Al-Khairy D; Ingalls RR Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230 [TBL] [Abstract][Full Text] [Related]
42. Herpes simplex virus type-1 induces IFN-alpha production via Toll-like receptor 9-dependent and -independent pathways. Hochrein H; Schlatter B; O'Keeffe M; Wagner C; Schmitz F; Schiemann M; Bauer S; Suter M; Wagner H Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11416-21. PubMed ID: 15272082 [TBL] [Abstract][Full Text] [Related]
43. Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides. Martin-Armas M; Simon-Santamaria J; Pettersen I; Moens U; Smedsrød B; Sveinbjørnsson B J Hepatol; 2006 May; 44(5):939-46. PubMed ID: 16458386 [TBL] [Abstract][Full Text] [Related]
44. The immunostimulatory activity of unmethylated and methylated CpG oligodeoxynucleotide is dependent on their ability to colocalize with TLR9 in late endosomes. de Jong SD; Basha G; Wilson KD; Kazem M; Cullis P; Jefferies W; Tam Y J Immunol; 2010 Jun; 184(11):6092-102. PubMed ID: 20427776 [TBL] [Abstract][Full Text] [Related]
45. Decreased intracellular TLR9 confers hyporesponsiveness of RAW264.7 cells to subsequent CpG ODN challenge. Wei L; Hong Z; Jiang Z; Guofu D; Hongwei C; Liangxi W; Yongling L; Bin L; Ping L Int Immunopharmacol; 2006 Jun; 6(6):935-46. PubMed ID: 16644479 [TBL] [Abstract][Full Text] [Related]
46. TLR9-dependent systemic interferon-beta production by intravenous injection of plasmid DNA/cationic liposome complex in mice. Yoshida H; Nishikawa M; Yasuda S; Mizuno Y; Toyota H; Kiyota T; Takahashi R; Takakura Y J Gene Med; 2009 Aug; 11(8):708-17. PubMed ID: 19462411 [TBL] [Abstract][Full Text] [Related]
51. Cell-specific TLR9 trafficking in primary APCs of transgenic TLR9-GFP mice. Avalos AM; Kirak O; Oelkers JM; Pils MC; Kim YM; Ottinger M; Jaenisch R; Ploegh HL; Brinkmann MM J Immunol; 2013 Jan; 190(2):695-702. PubMed ID: 23241879 [TBL] [Abstract][Full Text] [Related]
52. Sensing the hybrid--a novel PAMP for TLR9. Jensen SB; Paludan SR EMBO J; 2014 Mar; 33(6):529-30. PubMed ID: 24521669 [TBL] [Abstract][Full Text] [Related]
53. Deoxyribonuclease II is a lysosomal barrier to transfection. Howell DP; Krieser RJ; Eastman A; Barry MA Mol Ther; 2003 Dec; 8(6):957-63. PubMed ID: 14664798 [TBL] [Abstract][Full Text] [Related]
54. Lactobacillus plantarum induces genomic DNA-dependent and TLR9-mediated elafin secretion from Caco-2 cells. Hiramatsu Y; Sakamoto D; Satho T; Irie K; Miake F; Maeda M; Kashige N Asian Pac J Allergy Immunol; 2019 Mar; 37(1):36-42. PubMed ID: 29888925 [TBL] [Abstract][Full Text] [Related]
55. Biogenesis and proteolytic processing of lysosomal DNase II. Ohkouchi S; Shibata M; Sasaki M; Koike M; Safig P; Peters C; Nagata S; Uchiyama Y PLoS One; 2013; 8(3):e59148. PubMed ID: 23516607 [TBL] [Abstract][Full Text] [Related]